The Safety and Immunogenicity of a 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT) in 12-23-Month Children: A Double-Blind, Randomized, Phase III Trial in China. [PDF]
Xie Z +11 more
europepmc +1 more source
Pneumococcal Vaccination of Adults in Italy: What Strategies? [PDF]
Massaro E, Gabutti G.
europepmc +1 more source
PCV20 in pediatric pneumococcal prevention: expanded coverage, remaining challenges. [PDF]
Principi N +3 more
europepmc +1 more source
Changes in 23-valent pneumococcal polysaccharide vaccination rate and associated factors in 2022 and 2024 among community-based older adults in Shanghai, China. [PDF]
Jia Y +5 more
europepmc +1 more source
Distinct effects of adjuvants on B cell responses to protein or polysaccharide antigens contained in glycoconjugate vaccines. [PDF]
Budroni S +13 more
europepmc +1 more source
Lot-to-lot consistency, immunogenicity, and safety of a 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy adults aged 40-65 years: A randomized, double-blind, controlled, phase IV clinical trial. [PDF]
Zhang Y +15 more
europepmc +1 more source
Challenges and recommendations of vaccination in immunosuppression. [PDF]
Martins CAO +3 more
europepmc +1 more source
Nanoparticle-Based Antiviral Vaccines for Chickens: Recent Advances and Future Perspectives. [PDF]
Ding P, Xia L, Dong S.
europepmc +1 more source

